Immunic, Inc. is trading approximately 9.6% up in after-hours trading at $14.00 amid a broad biotech rebound following a rates-driven selloff.
- The stock is rebounding from a sharp 11.5% drop to $12.77 at the June 5 close.
- The move comes without fresh company-specific headlines and appears tied to a modest bounce in risk sentiment rather than a new fundamental catalyst for Immunic, Inc.